
Michael J. Schmitt
Examiner (ID: 12923, Phone: (571)270-7047 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629 |
| Total Applications | 806 |
| Issued Applications | 444 |
| Pending Applications | 71 |
| Abandoned Applications | 317 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9223615
[patent_doc_number] => 20140018389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'Hepatitis C Virus Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/027531
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92155
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14027531
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/027531 | Hepatitis C Virus Inhibitors | Sep 15, 2013 | Abandoned |
Array
(
[id] => 9397093
[patent_doc_number] => 20140094499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'FORMULATIONS OF (R)-1-(2,2-DIFLUOROBENZO[D] [1,3] DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANECARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/027791
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15785
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14027791
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/027791 | FORMULATIONS OF (R)-1-(2,2-DIFLUOROBENZO[D] [1,3] DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANECARBOXAMIDE | Sep 15, 2013 | Abandoned |
Array
(
[id] => 9642042
[patent_doc_number] => 20140220152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress'
[patent_app_type] => utility
[patent_app_number] => 14/025750
[patent_app_country] => US
[patent_app_date] => 2013-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 60548
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025750
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/025750 | Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress | Sep 11, 2013 | Abandoned |
Array
(
[id] => 9269196
[patent_doc_number] => 20140024113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/020099
[patent_app_country] => US
[patent_app_date] => 2013-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 22303
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14020099
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/020099 | Compounds for treating cancer and other diseases | Sep 5, 2013 | Issued |
Array
(
[id] => 11250275
[patent_doc_number] => 09475766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Substituted aromatic sulfur compounds and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 13/975483
[patent_app_country] => US
[patent_app_date] => 2013-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27775
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13975483
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/975483 | Substituted aromatic sulfur compounds and methods of their use | Aug 25, 2013 | Issued |
Array
(
[id] => 9331098
[patent_doc_number] => 20140057880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'ANTCIN DERIVATIVES IN COMBINATION WITH ANTI-CANCER DRUGS IN THE TREATMENT AND/OR PREVENTION OF TUMORS'
[patent_app_type] => utility
[patent_app_number] => 13/974487
[patent_app_country] => US
[patent_app_date] => 2013-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8127
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13974487
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/974487 | ANTCIN DERIVATIVES IN COMBINATION WITH ANTI-CANCER DRUGS IN THE TREATMENT AND/OR PREVENTION OF TUMORS | Aug 22, 2013 | Abandoned |
Array
(
[id] => 10621601
[patent_doc_number] => 09340538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Dihydropyrimidine compounds and their application in pharmaceuticals'
[patent_app_type] => utility
[patent_app_number] => 14/416061
[patent_app_country] => US
[patent_app_date] => 2013-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70901
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416061
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/416061 | Dihydropyrimidine compounds and their application in pharmaceuticals | Aug 22, 2013 | Issued |
Array
(
[id] => 10327083
[patent_doc_number] => 20150212087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'Detection of the ERalpha/Src/PI3K Complex as Predictive Marker in Breast Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/417269
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6695
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417269
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417269 | Detection of the ERalpha/Src/PI3K Complex as Predictive Marker in Breast Cancer | Jul 25, 2013 | Abandoned |
Array
(
[id] => 9135714
[patent_doc_number] => 20130296429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/937107
[patent_app_country] => US
[patent_app_date] => 2013-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 24276
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13937107
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/937107 | L-ornithine phenyl acetate and methods of making thereof | Jul 7, 2013 | Issued |
Array
(
[id] => 9309452
[patent_doc_number] => RE044768
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2014-02-18
[patent_title] => 'Rapamycin hydroxyesters'
[patent_app_type] => reissue
[patent_app_number] => 13/931400
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7095
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931400
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/931400 | Rapamycin hydroxyesters | Jun 27, 2013 | Issued |
Array
(
[id] => 9123095
[patent_doc_number] => 20130290017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'Methods and Compositions for the Prevention and Treatment of Kidney Disease'
[patent_app_type] => utility
[patent_app_number] => 13/929559
[patent_app_country] => US
[patent_app_date] => 2013-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6599
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929559
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/929559 | Methods and Compositions for the Prevention and Treatment of Kidney Disease | Jun 26, 2013 | Abandoned |
Array
(
[id] => 12008535
[patent_doc_number] => 09801832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction'
[patent_app_type] => utility
[patent_app_number] => 14/410221
[patent_app_country] => US
[patent_app_date] => 2013-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 11241
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410221
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/410221 | Pharmaceutical composition having synergistic action of direct catalase inhibitors and modulators of no metabolism or of extracellular superoxide anion production which lead to catalase destruction | Jun 19, 2013 | Issued |
Array
(
[id] => 9192095
[patent_doc_number] => 20130331410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => '2,3-DIHYDROFURO[2,3-c]PYRIDIN-2-YLPIPERIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/911138
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13121
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911138
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911138 | 2,3-dihydrofuro[2,3-c]pyridin-2-ylpiperidine derivatives | Jun 5, 2013 | Issued |
Array
(
[id] => 10265896
[patent_doc_number] => 20150150893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION'
[patent_app_type] => utility
[patent_app_number] => 14/406206
[patent_app_country] => US
[patent_app_date] => 2013-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22258
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406206 | ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION | May 30, 2013 | Abandoned |
Array
(
[id] => 9657379
[patent_doc_number] => 20140228384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'ASSAYS AND BIOMARKERS FOR LRRK2'
[patent_app_type] => utility
[patent_app_number] => 13/904922
[patent_app_country] => US
[patent_app_date] => 2013-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 47524
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13904922
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/904922 | ASSAYS AND BIOMARKERS FOR LRRK2 | May 28, 2013 | Abandoned |
Array
(
[id] => 9055315
[patent_doc_number] => 20130253030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'METHODS OF TREATING MIXED DYSLIPIDEMIA'
[patent_app_type] => utility
[patent_app_number] => 13/898447
[patent_app_country] => US
[patent_app_date] => 2013-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26697
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13898447
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/898447 | Methods of treating mixed dyslipidemia | May 19, 2013 | Issued |
Array
(
[id] => 9375879
[patent_doc_number] => 08680144
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Methods of treating mixed dyslipidemia'
[patent_app_type] => utility
[patent_app_number] => 13/898457
[patent_app_country] => US
[patent_app_date] => 2013-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 26707
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13898457
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/898457 | Methods of treating mixed dyslipidemia | May 19, 2013 | Issued |
Array
(
[id] => 10202634
[patent_doc_number] => 20150087622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'NEW METHOD OF USE OF A PESTICIDE'
[patent_app_type] => utility
[patent_app_number] => 14/394279
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6245
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394279
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/394279 | NEW METHOD OF USE OF A PESTICIDE | May 1, 2013 | Abandoned |
Array
(
[id] => 9041088
[patent_doc_number] => 20130243726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'METHODS FOR TREATING HCV'
[patent_app_type] => utility
[patent_app_number] => 13/875252
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59636
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875252
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875252 | Methods for treating HCV | Apr 30, 2013 | Issued |
Array
(
[id] => 9909020
[patent_doc_number] => 20150064221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'COMPOUNDS HAVING IMMUNOMUDULATOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/395252
[patent_app_country] => US
[patent_app_date] => 2013-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15848
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395252
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/395252 | COMPOUNDS HAVING IMMUNOMUDULATOR ACTIVITY | Apr 16, 2013 | Abandoned |